Form 4: GeneDx Holdings CFO Sells Shares to Cover Tax Obligations

GeneDx Holdings CFO, Kevin Feeley, sold shares to cover tax obligations related to the vesting of restricted stock units.

Summary

• GeneDx Holdings CFO, Kevin Feeley, engaged in transactions involving the company's Class A Common Stock on December 9, 2024.
• He acquired 2,462 shares through the vesting of restricted stock units (RSUs).
• He sold 1,137 shares at a weighted average price of $76.3728 per share to cover tax withholding obligations.
• The sale was not a discretionary transaction but rather a 'sell to cover' to meet tax obligations.
• The shares were sold in multiple transactions at prices ranging from $76.37 to $76.8317 per share.
• The RSUs vest in quarterly installments over a 4-year period starting March 9, 2023.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation. It is neither particularly positive nor negative, but rather a standard financial procedure.

Positives

• The transaction is a standard procedure for covering tax obligations related to RSU vesting.

Industry Context

This type of transaction is common for executives who receive stock-based compensation, and it is not unusual for them to sell shares to cover tax obligations.

Comparison to Industry Standards

• The 'sell to cover' transaction is a standard practice across many publicly traded companies, including those in the biotechnology and healthcare sectors.
• Similar transactions are frequently seen in filings from companies like Illumina, Inc. and Thermo Fisher Scientific, where executives often receive stock options and RSUs as part of their compensation packages.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates

Keywords

GeneDx Holdings, CFO, Kevin Feeley, Class A Common Stock, Restricted Stock Units, RSU, Tax Withholding, Sell to Cover, Share Sale